Research and Markets: Gouty Arthritis (Gout) - Pipeline Review, H2 2011

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/26b4d9/gouty_arthritis_g) has announced the addition of Global Markets Direct's new report "Gouty Arthritis (Gout) - Pipeline Review, H2 2011" to their offering.

'Gouty Arthritis (Gout) - Pipeline Review, H2 2011', provides an overview of the Gouty Arthritis (Gout) therapeutic pipeline. This report provides information on the therapeutic development for Gouty Arthritis (Gout), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Gouty Arthritis (Gout). 'Gouty Arthritis (Gout) - Pipeline Review, H2 2011' is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources

Scope

  • A snapshot of the global therapeutic scenario for Gouty Arthritis (Gout).
  • A review of the Gouty Arthritis (Gout) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • Coverage of products based on various stages of development ranging from discovery till registration stages.
  • A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
  • Coverage of the Gouty Arthritis (Gout) pipeline on the basis of route of administration and molecule type.
  • Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
  • Key discontinued pipeline projects.
  • Latest news and deals relating to the products.

Reasons to buy

  • Identify and understand important and diverse types of therapeutics under development for Gouty Arthritis (Gout).
  • Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
  • Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
  • Devise corrective measures for pipeline projects by understanding Gouty Arthritis (Gout) pipeline depth and focus of Gouty Arthritis (Gout) therapeutics.

For more information visit http://www.researchandmarkets.com/research/26b4d9/gouty_arthritis_g

Contacts

Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716